These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 38927691)

  • 1. Integrated Analysis of scRNA-Seq and Bulk RNA-Seq Reveals Metabolic Reprogramming of Liver Cancer and Establishes a Prognostic Risk Model.
    Xiong Z; Li L; Wang G; Guo L; Luo S; Liao X; Liu J; Teng W
    Genes (Basel); 2024 Jun; 15(6):. PubMed ID: 38927691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Constructing immune and prognostic features associated with ADCP in hepatocellular carcinoma and pan-cancer based on scRNA-seq and bulk RNA-seq.
    Zhang Z; Li Y; Quan Z; Li Y; Zhu L; Sun S; Chen X
    Front Immunol; 2024; 15():1397541. PubMed ID: 38774870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive analysis of scRNA-Seq and bulk RNA-Seq reveals dynamic changes in the tumor immune microenvironment of bladder cancer and establishes a prognostic model.
    Tan Z; Chen X; Zuo J; Fu S; Wang H; Wang J
    J Transl Med; 2023 Mar; 21(1):223. PubMed ID: 36973787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Based on scRNA-seq and bulk RNA-seq to establish tumor immune microenvironment-associated signature of skin melanoma and predict immunotherapy response.
    Li S; Zhao J; Wang G; Yao Q; Leng Z; Liu Q; Jiang J; Wang W
    Arch Dermatol Res; 2024 May; 316(6):262. PubMed ID: 38795156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of tumor endothelial cells (TEC) in gastric cancer and development of a TEC-based risk signature using single-cell RNA-seq and bulk RNA-seq data.
    Fan M; Xu X; Hu Y
    Aging (Albany NY); 2024 Jun; 16(12):10252-10270. PubMed ID: 38870270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting nucleotide metabolic pathways in colorectal cancer by integrating scRNA-seq, spatial transcriptome, and bulk RNA-seq data.
    Zhao S; Zhang P; Niu S; Xie J; Liu Y; Liu Y; Zhao N; Cheng C; Lu P
    Funct Integr Genomics; 2024 Apr; 24(2):72. PubMed ID: 38594466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integration of single-cell RNA-seq and bulk RNA-seq to construct liver hepatocellular carcinoma stem cell signatures to explore their impact on patient prognosis and treatment.
    Liu L; Zhang M; Cui N; Liu W; Di G; Wang Y; Xi X; Li H; Shen Z; Gu M; Wang Z; Jiang S; Liu B
    PLoS One; 2024; 19(4):e0298004. PubMed ID: 38635528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive scRNA-seq Analysis and Identification of CD8_+T Cell Related Gene Markers for Predicting Prognosis and Drug Resistance of Hepatocellular Carcinoma.
    Cao L; Liu M; Ma X; Rong P; Zhang J; Wang W
    Curr Med Chem; 2024; 31(17):2414-2430. PubMed ID: 37936457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterizing cancer metabolism from bulk and single-cell RNA-seq data using METAFlux.
    Huang Y; Mohanty V; Dede M; Tsai K; Daher M; Li L; Rezvani K; Chen K
    Nat Commun; 2023 Aug; 14(1):4883. PubMed ID: 37573313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. M2-like tumor-associated macrophage-related biomarkers to construct a novel prognostic signature, reveal the immune landscape, and screen drugs in hepatocellular carcinoma.
    Qu X; Zhao X; Lin K; Wang N; Li X; Li S; Zhang L; Shi Y
    Front Immunol; 2022; 13():994019. PubMed ID: 36177006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrative analysis reveals a four-gene signature for predicting survival and immunotherapy response in colon cancer patients using bulk and single-cell RNA-seq data.
    Chai R; Zhao Y; Su Z; Liang W
    Front Oncol; 2023; 13():1277084. PubMed ID: 38023180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unveiling major histocompatibility complex-mediated pan-cancer immune features by integrated single-cell and bulk RNA sequencing.
    Feng HR; Shen XN; Zhu XM; Zhong WT; Zhu DX; Zhao J; Chen YJ; Shen F; Liu K; Liang L
    Cancer Lett; 2024 Aug; 597():217062. PubMed ID: 38878852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrated analysis of single-cell RNA-seq and bulk RNA-seq unveils heterogeneity and establishes a novel signature for prognosis and tumor immune microenvironment in ovarian cancer.
    Wang Z; Zhang J; Dai F; Li B; Cheng Y
    J Ovarian Res; 2023 Jan; 16(1):12. PubMed ID: 36642706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and validation a prognostic model based on natural killer T cells marker genes for predicting prognosis and characterizing immune status in glioblastoma through integrated analysis of single-cell and bulk RNA sequencing.
    Hu J; Xu L; Fu W; Sun Y; Wang N; Zhang J; Yang C; Zhang X; Zhou Y; Wang R; Zhang H; Mou R; Du X; Li X; Hu S; Xie R
    Funct Integr Genomics; 2023 Aug; 23(3):286. PubMed ID: 37650991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IGFBP7+ subpopulation and IGFBP7 risk score in astrocytoma: insights from scRNA-Seq and bulk RNA-Seq.
    Zhao L; Shao W; Xiahou Z; Ren L; Liu C; Song Y; Xu H; Wang Z; Xing J
    Front Immunol; 2024; 15():1434300. PubMed ID: 39403379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single-cell and bulk RNA sequencing reveal heterogeneity and diagnostic markers in papillary thyroid carcinoma lymph-node metastasis.
    Lu DN; Zhang WC; Lin YZ; Jiang HY; He R; Li SL; Zhang YN; Shao CY; Zheng CM; Xu JJ; Ge MH
    J Endocrinol Invest; 2024 Jun; 47(6):1513-1530. PubMed ID: 38146045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrated analysis of single-cell RNA-seq and bulk RNA-seq unravels T cell-related prognostic risk model and tumor immune microenvironment modulation in triple-negative breast cancer.
    Guo S; Liu X; Zhang J; Huang Z; Ye P; Shi J; Stalin A; Wu C; Lu S; Zhang F; Gao Y; Jin Z; Tao X; Huang J; Zhai Y; Shi R; Guo F; Zhou W; Wu J
    Comput Biol Med; 2023 Jul; 161():107066. PubMed ID: 37263064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integration of single-cell sequencing and bulk RNA-seq to identify and develop a prognostic signature related to colorectal cancer stem cells.
    Wu J; Li W; Su J; Zheng J; Liang Y; Lin J; Xu B; Liu Y
    Sci Rep; 2024 May; 14(1):12270. PubMed ID: 38806611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel defined programmed cell death related gene signature for predicting the prognosis of serous ovarian cancer.
    Zhan F; Guo Y; He L
    J Ovarian Res; 2024 Apr; 17(1):92. PubMed ID: 38685095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combining single-cell sequencing and spatial transcriptome sequencing to identify exosome-related features of glioblastoma and constructing a prognostic model to identify BARD1 as a potential therapeutic target for GBM patients.
    Zhao S; Wang Q; Ni K; Zhang P; Liu Y; Xie J; Ji W; Cheng C; Zhou Q
    Front Immunol; 2023; 14():1263329. PubMed ID: 37727789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.